To rule out loss of Tet-regulation of MEK as a mechanism(s) of resistance responsible for mediating tumor recurrence, we evaluated all tumor tissue for expression of virally delivered MEK by immunoblotting and immunohistochemistry (IHC) for the HA epitope tag on MEK (Figure 5d). The gene discussed is MAP2K7; the disease is neoplasm.